Uzzan, Joel http://orcid.org/0000-0001-6686-4854
Mapani, Adam
Cox, Oliver
Bagijn, Marloes
Saffar, Insaf
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Article History
Received: 18 June 2024
Accepted: 16 July 2024
First Online: 27 July 2024
Declarations
:
: Joel Uzzan: Consultant and Investigator: Apellis, Bayer, Bausch + Lomb, F. Hoffmann-La Roche Ltd., Horus, and Novartis. Adam Mapani: Educational, travel, and research grants, advisory board, and speaker’s fees: AbbVie, Alimera, Apellis, Bayer, Biogen, BVI, F. Hoffmann-La Roche Ltd., Gyroscope, Novartis, Scope International, and Veni-Vidi. Marloes Bagijn, Oliver Cox, and Insaf Saffar: Employee: F. Hoffmann-La Roche Ltd.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.